The C protein of measles virus inhibits the type I interferon response

Virology

Volumn 315, Issue 2, 2003, Pages 389-397

  Shaffer, Jessica A ^a,b   Bellini, William J ^a   Rota, Paul A ^a,c  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

C protein; Cytokine; Interferon; Measles; Morbillivirus; Paramyxovirus

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; NEUTRALIZING ANTIBODY; PLASMID DNA; PROTEIN C; VIRULENCE FACTOR; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INHIBITION KINETICS; MEASLES VIRUS; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; VIROGENESIS; VIRUS STRAIN; VIRUS VIRULENCE;

MEASLES VIRUS; MORBILLIVIRUS; PARAMYXOVIRIDAE;

EID: 0142154183     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00537-3     Document Type: Article

References (53)

1. Andrejeva J., Young D.F., Goodbourn S., Randall R.E. Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively consequences for virus replication in the presence of alpha/beta and gamma interferons . J. Virol. 76:2002;2159-2167.
2. Bellini W.J., Englund G., Rozenblatt S., Arnheiter H., Richardson C.D. Measles virus P gene codes for two proteins. J. Virol. 53:1985;908-919.
3. Calain P., Roux L. Generation of measles virus defective interfering particles and their presence in a preparation of attenuated live-virus vaccine. J. Virol. 62:1988;2859-2866.
4. Didcock L., Young D.F., Goodbourn S., Randall R.E. Sendai virus and simian virus 5 block activation of interferon-responsive genes importance for virus pathogenesis . J. Virol. 73:1999;3125-3133.
5. Didcock L., Young D.F., Goodbourn S., Randall R.E. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol. 73:1999;9928-9933.
6. Escoffier C., Manie S., Vincent S., Muller C.P., Billeter M., Gerlier D. Nonstructural C protein is required for efficient measles virus replication in human peripheral blood cells. J Virol. 73:1999;1168-1695.
7. Fujii N., Kimura K., Murakami T., Indoh T., Ishida S., Fujinaga K., Oguma K. Suppression of interferon-induced oligo-2′,5′-adenylate synthetase induction in persistent infection. J. Gen. Virol. 71:1990;3071-3074.
8. Gao J., De B.P., Han Y., Choudhary S., Ransohoff R., Banerjee A.K. Human parainfluenza virus type 3 inhibits gamma interferon-induced major histocompatibility complex class II expression directly and by inducing alpha/beta interferon. J. Virol. 75:2001;1124-1131.
9. Garcin D., Curran J., Itoh M., Kolakofsky D. Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response. J. Virol. 75:2001;6800-6807.
10. Garcin D., Curran J., Kolakofsky D. Sendai virus C proteins must interact directly with cellular components to interfere with interferon action. J. Virol. 74:2000;8823-8830.
11. Garcin D., Latorre P., Kolakofsky D. Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J. Virol. 73:1999;6559-6565.
12. Garcin D., Marq J.B., Strahle L., le Mercier P., Kolakofsky D. All four Sendai virus C proteins bind Stat1, but only the larger forms also induce its mono-ubiquitination and degradation. Virology. 295:2002;256-265.
13. Goodbourn S., Didcock L., Randall R.E. Interferons cell signalling, immune modulation, antiviral response and virus countermeasures . J. Gen. Virol. 81:2000;2341-2364.
14. Gotoh B., Komatsu T., Takeuchi K., Yokoo J. Paramyxovirus accessory proteins as interferon antagonists. Microbiol. Immunol. 45:2001;787-800.
15. Gotoh B., Komatsu T., Takeuchi K., Yokoo J. Paramyxovirus strategies for evading the interferon response. Rev. Med. Virol. 12:2002;337-357.
16. Gotoh B., Takeuchi K., Komatsu T., Yokoo J., Kimura Y., Kurotani A., Kato A., Nagai Y. Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-alpha/beta-mediated responses. FEBS Lett. 459:1999;205-210.
17. Griffin, D.E., 2001. Measles virus, in: D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Straus (Eds.), Vol. 1, Fourth Edition, Lippincott, Williams, and Wilkins, Philadelphia, pp. 1401-1442.
18. Harcourt B.H., Tamin A., Ksiazek T.G., Rollin P.E., Anderson L.J., Bellini W.J., Rota P.A. Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology. 271:2000;334-349.
19. Kato A., Ohnishi Y., Kohase M., Saito S., Tashiro M., Nagai Y. Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis. J. Virol. 75:2001;3802-3810.
20. King P., Goodbourn S. STAT1 is inactivated by a caspase. J. Biol. Chem. 273:1998;8699-8704.
21. Kobune F., Sakata H., Sugiura A. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J. Virol. 64:1990;700-705.
22. Komatsu T., Takeuchi K., Yokoo J., Gotoh B. Sendai virus C protein impairs both phosphorylation and dephosphorylation processes of Stat1. FEBS Lett. 511:2002;139-144.
23. Kubota T., Yokosawa N., Yokota S., Fujii N. Association of mumps virus V protein with RACK1 results in dissociation of STAT-1 from the alpha interferon receptor complex. J. Virol. 76:2002;12676-12682.
24. Lamb R., Kolakofsky D. Paramyxoviridae. Knipe D.M., Howley P.M. Fields Virology. Vol. 1:2001;1305-1340 Lippencott, Williams, and Wilkins, Philadelphia.
25. Maeno K., Yoshii S., Nagata I., Matsumoto T. Growth of Newcastle disease virus in a HVJ carrier culture of HeLa cells. Virology. 29:1966;255-263.
26. Mosca J.D., Pitha P.M. Transcriptional and posttranscriptional regulation of exogenous human beta interferon gene in simian cells defective in interferon synthesis. Mol. Cell. Biol. 6:1986;2279-2283.
27. Mrkic B., Odermatt B., Klein M.A., Billeter M.A., Pavlovic J., Cattaneo R. Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. J. Virol. 74:2000;1364-1372.
28. Naniche D., Yeh A., Eto D., Manchester M., Friedman R.M., Oldstone M.B. Evasion of host defenses by measles virus wild-type measles virus infection interferes with induction of Alpha/Beta interferon production . J. Virol. 74:2000;7478-7484.
29. Palosaari H., Parisien J., Rodriguez J., Ulane C., Horvath C. STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J. Virol. 77:2003;7635-7644.
30. Parisien J.P., Lau J.F., Horvath C.M. STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication. J. Virol. 76:2002;6435-6441.
31. Parisien J.P., Lau J.F., Rodriguez J.J., Sullivan B.M., Moscona A., Parks G.D., Lamb R.A., Horvath C.M. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology. 283:2001;230-239.
32. Parisien J.P., Lau J.F., Rodriguez J.J., Ulane C.M., Horvath C.M. Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction. J. Virol. 76:2002;4190-4198.
33. Patterson J.B., Thomas D., Lewicki H., Billeter M.A., Oldstone M.B. V and C proteins of measles virus function as virulence factors in vivo. Virology. 267:2000;80-89.
34. Radecke F., Billeter M.A. The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells. Virology. 217:1996;418-421.
35. Rodriguez J.J., Parisien J.P., Horvath C.M. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J. Virol. 76:2002;11476-11483.
36. Rota J.S., Wang Z.D., Rota P.A., Bellini W.J. Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res. 31:1994;317-330.
37. Saito S., Ogino T., Miyajima N., Kato A., Kohase M. Dephosphorylation failure of tyrosine-phosphorylated STAT1 in IFN-stimulated Sendai virus C protein-expressing cells. Virology. 293:2002;205-209.
38. Schneider H., Spielhofer P., Kaelin K., Dotsch C., Radecke F., Sutter G., Billeter M.A. Rescue of measles virus using a replication-deficient vaccinia-T7 vector. J. Virol. Methods. 64:1997;57-64.
39. Sen G.C., Biron C.A. Interferons and other cytokines. Howley P.M., Griffin D.E. Field's Virology. Vol. 1:2001;321-350 Lippincott, Williams, and Wilkins, Philadelphia.
40. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67:1998;227-264.
41. Takeuchi K., Kadota S., Takeda M., Miyajima N., Nagata K. Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation. FEBS Lett. 545:2003;177-182.
42. Thacore H.R., Lin H.Y., Davis P.J., Schoenl M. Effect of protein kinase C inhibitors on interferon-beta production by viral and non-viral inducers. J. Gen. Virol. 71:1990;2833-2839.
43. Valle M., Cantell K. The ability of Sendai virus to overcome cellular resistance to vesicular stomatitis virus. I. General characteristics of the system. Ann. Med. Exp. Biol. Fenn. 43:1965;57-60.
44. Valsamakis A., Schneider H., Auwaerter P.G., Kaneshima H., Billeter M.A., Griffin D.E. Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J. Virol. 72:1998;7754-7761.
45. Volckaert-Vervliet G., Billiau A. Induction of interferon in human lymphoblastoid cells by Sendai and measles viruses. J. Gen. Virol. 37:1977;199-203.
46. Volckaert-Vervliet G., Heremans H., De Ley M., Billiau A. Interferon induction and action in human lymphoblastoid cells infected with measles virus. J. Gen. Virol. 41:1978;459-466.
47. Whistler T., Bellini W.J., Rota P.A. Generation of defective interfering particles by two vaccine strains of measles virus. Virology. 220:1996;480-484.
48. WHO, 2002. Update: vaccines and immunization. WHO and UNICEF News, 1-2.
49. Yeh T.J., McBride P.T., Overall J.C. Jr., Green J.A. Automated, quantitative cytopathic effect reduction assay for interferon. J. Clin. Microbiol. 16:1982;413-415.
50. Yokosawa N., Yokota S., Kubota T., Fujii N. C-terminal region of STAT-1alpha is not necessary for its ubiquitination and degradation caused by mumps virus V protein. J. Virol. 76:2002;12683-12690.
51. Yokota S., Saito H., Kubota T., Yokosawa N., Amano K., Fujii N. Measles virus suppresses interferon-alpha signaling pathway suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-alpha receptor complex . Virology. 306:2003;135-146.
52. Young D.F., Chatziandreou N., He B., Goodbourn S., Lamb R.A., Randall R.E. Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells. J. Virol. 75:2001;3363-3370.
53. Young D.F., Didcock L., Goodbourn S., Randall R.E. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology. 269:2000;383-390.